Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 171

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Efficacy of Enalapril for Prevention of Congestive Heart Failure in Dogs with Myxomatous Valve Disease and Asymptomatic Mitral Regurgitation

Open access
Kvart, Clarence, Häggström, Jens, Pedersen, Henrik Duelund, Hansson, Kerstin, Eriksson, Anders, Järvinen, Anna-Kaisa, Tidholm, Anna, Bsenko, Karina, Ahlgren, Erik, Lives, Mikael, Åblad, Björn, Falk, Torkel, Bjerkås, Ellen, Gundler, Susanne, Lord, Peter, Wegeland, Gudrun, Adolfsson, Eva, Corfitzen, Jens·2002·Journal of Veterinary Internal Medicine

Abstract

We evaluated the long-term effect of early angiotensin-converting enzyme (ACE) inhibition (enalapril maleate) as monotherapy to postpone or prevent congestive heart failure (CHF) in asymptomatic dogs with mitral regurgitation (MR) attributable to myxomatous valvular disease (MVD) in a prospective, randomized, double-blinded, placebo-controlled multicenter trial involving 14 centers in Scandinavia. Two hundred twenty-nine Cavalier King Charles (CKC) Spaniels with MR attributable to MVD but no signs of CHF were randomly allocated to treatment with enalapril 0.25–0.5 mg daily (n = 116) or to placebo groups (n = 113). Each dog was evaluated by physical examination, electrocardiography, and thoracic radiography at entry and every 12 months (±30 days). The number of dogs developing heart failure was similar in the treatment and placebo groups (n = 50 [43%] and n = 48 [42%], respectively; P= .99). The estimated means, adjusted for censored observations, for the period from initiation of therapy to heart failure were 1,150 ± 50 days for dogs in the treatment group and 1,130 ± 50 days for dogs in the placebo group (P= .85). When absence or presence of cardiomegaly at the entrance of the trial was considered, there were still no differences between the treatment and placebo groups (P= .98 and .51, respectively). Multivariate analysis showed that enalapril had no significant effect on the time from initiation of therapy to heart failure (P= .86). Long-term treatment with enalapril in asymptomatic dogs with MVD and MR did not delay the onset of heart failure regardless of whether or not cardiomegaly was present at initiation of the study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1939-1676.2002.tb01610.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 171

Metadata

Authors
Kvart, C., Häggström, J., Pedersen, H. D., Hansson, K., Eriksson, A., Järvinen, A.-K., Tidholm, A., Bsenko, K., Ahlgren, E., Lives, M., Åblad, B., Falk, T., Bjerkås, E., Gundler, S., Lord, P., Wegeland, G., Adolfsson, E., & Corfitzen, J.
Venue
Journal of Veterinary Internal Medicine
Published
2002-01-01
Volume
16
Issue
1
Pages
80-88
ISSN
  • 0891-6640 (ISSN-L)
  • 1939-1676
OpenAlex
W1978050909
Cited by
171
References
3
FWCI
4.15
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of Enalapril for Prevention of Congestive Heart Failure in Dogs with Myxomatous Valve Disease and Asymptomatic Mitral Regurgitation. https://app.cochat.ai/papers/10.1111/j.1939-1676.2002.tb01610.x
The paper
Kvart, C., Häggström, J., Pedersen, H. D., Hansson, K., Eriksson, A., Järvinen, A.-K., Tidholm, A., Bsenko, K., Ahlgren, E., Lives, M., Åblad, B., Falk, T., Bjerkås, E., Gundler, S., Lord, P., Wegeland, G., Adolfsson, E., & Corfitzen, J. (2002). Efficacy of Enalapril for Prevention of Congestive Heart Failure in Dogs with Myxomatous Valve Disease and Asymptomatic Mitral Regurgitation. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/j.1939-1676.2002.tb01610.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.